Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (LTRN)

CUSIP: 51654W101

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
11,189,114
Total 13F shares
2,241,170
Share change
-184,544
Total reported value
$7,081,768
Put/Call ratio
0%
Price per share
$3.16
Number of holders
34
Value change
-$615,229
Number of buys
18
Number of sells
10

Quarterly Holders Quick Answers

What is CUSIP 51654W101?
CUSIP 51654W101 identifies LTRN - Lantern Pharma Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (LTRN) as of Q2 2025

As of 30 Jun 2025, Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (LTRN) was held by 34 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,241,170 shares. The largest 10 holders included BIOS Capital Management, LP, VANGUARD GROUP INC, CM Management, LLC, GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, NewEdge Advisors, LLC, Voss Capital, LP, BlackRock, Inc., DIMENSIONAL FUND ADVISORS LP, and Westside Investment Management, Inc.. This page lists 35 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.